
-
Iterum Therapeutics NASDAQ:ITRM
Location: | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing
Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
40.78M
Cash
11.72M
Avg Qtr Burn
-10.49M
Short % of Float
11.53%
Insider Ownership
1.81%
Institutional Own.
8.99%
Qtr Updated
06/30/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Sulopenem Details Urinary tract infection | Approved Quarterly sales | |
Sulopenem Details Intra-abdominal infections | Failed Discontinued | |
Sulopenem Details Urinary tract infection | Failed Discontinued |